FIELD: medicine, allergology.
SUBSTANCE: invention relates to treatment of allergic diseases, in particle, bronchial asthma. Invention proposes using black rice extract or pelargonidine, or cyanidine-glycoside for development of a therapeutic agent. These agents are used in the developed therapeutically effective doses. Invention provides effective treatment based on inhibition of accumulation of eosinophyles in cells of damaged tissues and organs.
EFFECT: enhanced and valuable medicinal properties of composition.
13 cl, 1 tbl, 4 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WAYS AND COMPOSITIONS FOR ADIPOSITY TREATMENT, INSULIN-DEPENDENT DISEASES AND HYPERCHOLESTERINEMIA | 2005 |
|
RU2359689C2 |
| NEW COMPOUND ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM, WITH A HIGH CONTENT OF ACTIVE INGREDIENT, COMPOSITION CONTAINING SAID COMPOUND FOR PREVENTING OR TREATING ALLERGIC DISEASE, INFLAMMATORY DISEASE, ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND USE THEREOF | 2015 |
|
RU2685732C2 |
| NEW INHIBITOR OF GLUTAMINYL CYCLASE AND ITS USE FOR TREATMENT OF LUNG AND RESPIRATORY DISEASES | 2017 |
|
RU2662559C1 |
| LACTOBACILLUS CRISPATUS KBL693 STRAIN AND ITS APPLICATION | 2019 |
|
RU2791561C2 |
| COMPOSITION FOR ASTHMA PREVENTION OR TREATMENT CONTAINING MONOACETHYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 |
|
RU2636615C2 |
| METHOD OF TREATMENT AND/OR PREVENTION OF ASTHMA, ASTHMA AGGRESSION, ALLERGIC ASTHMATIC DISORDERS AND/OR RESPIRATORY DISORDERS ASSOCIATED WITH MICROBIOTA | 2019 |
|
RU2800051C2 |
| MTB-C VACCINE AGAINST ASTHMA | 2012 |
|
RU2602771C2 |
| BIOLOGICAL MATERIALS AND THEIR USE | 2009 |
|
RU2508296C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING DERIVATIVES OF GLUTARIMIDES, AND THEIR APPLICATION FOR TREATMENT OF EOSINOPHILIC DISEASES | 2013 |
|
RU2552929C1 |
| NOVEL PEPTIDE-INHIBITOR PI3Kγ FOR TREATING RESPIRATORY DISEASES | 2015 |
|
RU2704826C2 |
